Click Here for 5% Off Your First Aladdin Purchase!

methylnaltrexone , CAS No.83387-25-1, Antagonist of δ receptor;Antagonist of κ receptor;Antagonist of μ receptor

  • Moligand™
Item Number
M611834
Grouped product items
SKUSizeAvailabilityPrice Qty
M611834-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,300.90
M611834-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,000.90

Basic Description

SynonymsMethylnaltrexone|Methylnaltrexonium|Naltrexone MB|N-Methylnaltrexone|83387-25-1|Quaternary ammonium naltrexone|MNTX|MRZ 2663|Mrz-2663|DTXSID20873339|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinanium-6-one|Methylnaltrexone ion|Morphinanium, 17-(c
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of δ receptor;Antagonist of κ receptor;Antagonist of μ receptor

Associated Targets

OPRD1 Tclin Delta-type opioid receptor 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRK1 Tclin Kappa-type opioid receptor 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRM1 Tclin Mu-type opioid receptor 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-3-ium-7-one
INCHI InChI=1S/C21H25NO4/c1-22(11-12-2-3-12)9-8-20-17-13-4-5-14(23)18(17)26-19(20)15(24)6-7-21(20,25)16(22)10-13/h4-5,12,16,19,25H,2-3,6-11H2,1H3/p+1/t16-,19+,20+,21-,22?/m1/s1
InChi Key JVLBPIPGETUEET-GAAHOAFPSA-O
Canonical SMILES O=C1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2[N+](CC3)(C)CC2CC2)ccc1O)O
Isomeric SMILES C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6
PubChem CID 5361918

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Li Z, Pergolizzi JV, Huttner RP, Zampogna G, Breve F, Raffa RB.  (2015)  Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs..  J Clin Pharm Ther,  40  (6): (615-9).  [PMID:26573866]

Solution Calculators